Vitafoods Insights Podcast

Cannabinoids may have a role to play to help address the toll the pandemic has had on consumers’ physical and mental well-being.  COVID-19 has a global game changer: daily routines and work habits have been completely turned upside-down. The perpetual stress and immobility, permeated with a sense of uncertainty, has impacted consumers' physical and mental well-being. However, this poses an opportunity for cannabinoids such as CBD to support consumer health in the post-COVID environment, demonstrating again the power contained in this powerful botanical. In this podcast, sponsored by Linnea, Nora Rossini, scientific affairs manager, discusses the whitespace market opportunities. Tune in to hear more about: How cannabinoids such as CBD and CBG impact physical and mental well-being. How studies around the ability of CBD to impact inflammatory markers and cognitive performance could inform future clinical research studies. Regulatory considerations companies must look at when bringing CBD products to market.